HK1145343A1 - 線粒體 缺失用於檢測癌症 - Google Patents

線粒體 缺失用於檢測癌症

Info

Publication number
HK1145343A1
HK1145343A1 HK10111822.9A HK10111822A HK1145343A1 HK 1145343 A1 HK1145343 A1 HK 1145343A1 HK 10111822 A HK10111822 A HK 10111822A HK 1145343 A1 HK1145343 A1 HK 1145343A1
Authority
HK
Hong Kong
Prior art keywords
dna
cancer
detection
deletion
mitochondrial
Prior art date
Application number
HK10111822.9A
Other languages
English (en)
Inventor
瑞安‧帕爾
羅伯特‧塞耶
加百利‧道庫博
珍妮佛‧克里德
克里‧魯賓遜
安德列婭‧馬格拉
布賴恩‧賴古伊
Original Assignee
Mitomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitomics Inc filed Critical Mitomics Inc
Publication of HK1145343A1 publication Critical patent/HK1145343A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
HK10111822.9A 2007-09-26 2010-12-17 線粒體 缺失用於檢測癌症 HK1145343A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2007/001711 WO2009039601A1 (en) 2007-09-26 2007-09-26 3.4 kb mitochondrial dna deletion for use in the detection of cancer

Publications (1)

Publication Number Publication Date
HK1145343A1 true HK1145343A1 (zh) 2011-04-15

Family

ID=40510689

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10111822.9A HK1145343A1 (zh) 2007-09-26 2010-12-17 線粒體 缺失用於檢測癌症

Country Status (11)

Country Link
EP (2) EP2634267B1 (zh)
JP (1) JP5518715B2 (zh)
KR (1) KR101449562B1 (zh)
CN (1) CN101874119B (zh)
AU (1) AU2007359381B2 (zh)
CA (1) CA2700941A1 (zh)
ES (2) ES2484044T3 (zh)
HK (1) HK1145343A1 (zh)
NZ (1) NZ584815A (zh)
SG (1) SG185254A1 (zh)
WO (1) WO2009039601A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2220252B1 (en) 2007-11-09 2018-03-14 MDNA Life Sciences Inc. Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer
WO2010115261A1 (en) 2009-03-27 2010-10-14 Genesis Genomics Inc. Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
KR101819852B1 (ko) 2008-03-28 2018-02-28 엠디엔에이 라이프 사이언시즈 인코퍼레이티드 비정상적인 미토콘드리아 ｄｎａ, 그것에 연관된 융합 트랜스크립트 및 혼성화 프로브

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005506057A (ja) * 2001-06-11 2005-03-03 １３０４８５４ オンタリオ・リミテッド 健康科学のための診断ツールとしての全ミトコンドリアゲノム配列
US20050026167A1 (en) * 2001-06-11 2005-02-03 Mark Birch-Machin Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
DE602006017534D1 (de) 2005-04-18 2010-11-25 Mitomics Inc Mitochondriale mutationen und umlagerungen als diagnostisches werkzeug zum nachweis von sonneneinstrahlung, prostatakrebs und anderen krebserkrankungen

Also Published As

Publication number Publication date
CA2700941A1 (en) 2009-04-02
JP2010539908A (ja) 2010-12-24
CN101874119B (zh) 2015-01-28
CN101874119A (zh) 2010-10-27
EP2634267A1 (en) 2013-09-04
WO2009039601A1 (en) 2009-04-02
JP5518715B2 (ja) 2014-06-11
KR20100069670A (ko) 2010-06-24
NZ584815A (en) 2012-07-27
AU2007359381A1 (en) 2009-04-02
EP2203570A1 (en) 2010-07-07
EP2203570A4 (en) 2010-09-01
EP2203570B1 (en) 2014-04-23
EP2634267B1 (en) 2015-02-18
AU2007359381B2 (en) 2015-06-18
KR101449562B1 (ko) 2014-10-13
ES2484044T3 (es) 2014-08-08
SG185254A1 (en) 2012-11-29
ES2539001T3 (es) 2015-06-25

Similar Documents

Publication Publication Date Title
SI2217578T1 (sl) (1,2,4)triazolo(1,5-a)piridinske in (1,2,4)triazolo(1,5-c)pirimidinske spojine in njihova uporaba
BRPI1004572A2 (pt) "fusões genéticas recorrentes em câncer
ZA200903173B (en) Cancer susceptibility variants on chr8q24.21
PL2101731T3 (pl) Endoksyfen do zastosowania w leczeniu nowotworu
IL198010A0 (en) Phenylpropionamide compounds and the use thereof
HK1131140A1 (zh) 取代的脯氨酰胺、及其用途
GB0724881D0 (en) Methods for the detection of colorectal cancer
HK1170485A1 (zh) -噻唑烷- -酮衍生物及其在癌症治療中的用途
EP2167083A4 (en) NOVEL HETEROARYL-3-AZABICYCLOÝ3.1.0HEXANES, THEIR METHODS OF PREPARATION AND THEIR USE AS MEDICAMENTS
IL193155A0 (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
MX303262B (es) Composicion de locion para uso personal.
AU2006251167A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
PL2235013T3 (pl) Podstawione związki tetrahydroimidazopirydynowe i ich zastosowanie w farmaceutykach
IL208168A0 (en) Tetrahydroisoquinoline derivatives, compositions comprising the same and use thereof
IL206189A0 (en) Compound for use in the treatment of cancer
HK1145343A1 (zh) 線粒體 缺失用於檢測癌症
EP2220252A4 (en) SUPPRESSION OF MITOCHONDRIAL DNA MUTATIONS BETWEEN RESIDUES 12317-16254 FOR USE IN THE DETECTION OF CANCER
SG10201600490PA (en) 3.4 kb Mitochondrial DNA Deletion for use in the Detection of Cancer
SG10202008082XA (en) 3.4 kb Mitochondrial DNA Deletion for use in the Detection of Cancer
Westerhoff Set in our Ways
GB0707514D0 (en) Saftey line
IL206379A0 (en) 17-HYDROXY-19-NOR-21-CARBOXYLIC ACID-STEROID ã?-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING THE DERIVATIVE
Lowitt The employment creation potential of recycling in South Africa
Basnayake et al. The Sculpture of Polonnaruwa
Guiffrida et al. Taking time to listen.